pioglitazone has been researched along with Intertrochanteric Fractures in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colhoun, HM | 1 |
| Livingstone, SJ | 1 |
| Looker, HC | 1 |
| Morris, AD | 1 |
| Wild, SH | 1 |
| Lindsay, RS | 1 |
| Reed, C | 1 |
| Donnan, PT | 1 |
| Guthrie, B | 1 |
| Leese, GP | 1 |
| McKnight, J | 1 |
| Pearson, DW | 1 |
| Pearson, E | 1 |
| Petrie, JR | 1 |
| Philip, S | 1 |
| Sattar, N | 1 |
| Sullivan, FM | 1 |
| McKeigue, P | 1 |
1 other study available for pioglitazone and Intertrochanteric Fractures
| Article | Year |
|---|---|
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs.
Topics: Age Distribution; Aged; Databases, Factual; Diabetes Mellitus, Type 2; Drug Prescriptions; Female; F | 2012 |